Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT studyReinhard Dummer, Michael R. Migden, Ralf Gutzmer et al.|British Journal of Dermatology|2019Cited by 197